CEA is a recommended prognostic marker for monitoring tumor progression in colon cancer [16–19], and examining 12 nodes might be insufficient for CEA-elevated colon cancer patients who were characterized by higher risk of lymph node metastasis and poor prognosis. This evidence concerns the gene CEACAM5 and metastatic malignant neoplasm in the lymph nodes.